Cargando…
Immunotherapies in sarcoma: Updates and future perspectives
Sarcomas are malignant tumors that are characterized by a wide diversity of subtypes with various cytogenetic profiles. Despite major treatment breakthroughs, standard treatment modalities combining chemotherapy, radiotherapy, and surgery failed to improve overall survival. Therefore, high expectati...
Autores principales: | Ghosn, Marwan, El Rassy, Elie, Kourie, Hampig Raphael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385435/ https://www.ncbi.nlm.nih.gov/pubmed/28439495 http://dx.doi.org/10.5306/wjco.v8.i2.145 |
Ejemplares similares
-
Dilemma of first line regimens in metastatic pancreatic adenocarcinoma
por: Ghosn, Marwan, et al.
Publicado: (2016) -
Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature
por: Ghosn, Marwan, et al.
Publicado: (2016) -
Checkpoint inhibitors in gastrointestinal cancers: Expectations and reality
por: Kourie, Hampig Raphael, et al.
Publicado: (2017) -
Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence
por: Moujaess, Elissar, et al.
Publicado: (2020) -
The future of cancer research after COVID-19 pandemic: recession?
por: Kourie, Hampig Raphael, et al.
Publicado: (2020)